Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
about
Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control.A Practical Review of C-Peptide Testing in DiabetesParenteral insulin suppresses T cell proliferation to islet antigens.Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patientsInsulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset.Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth studyPlasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetesStrategies for clinical trials in type 1 diabetesImmunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the futureThe role of immunomodulation therapy in autoimmune diabetesActivated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.GABAergic system in β-cells: from autoimmunity target to regeneration tool.Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.Coincidence of PTPN22 c.1858CC and FCRL3 -169CC genotypes as a biomarker of preserved residual β-cell function in children with type 1 diabetes.Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes.The impact of insulin administration during the mixed meal tolerance test.Simple measures to monitor beta-cell mass and assess islet graft dysfunction.Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus
P2860
Q33683730-057C3FCC-3BB5-4DA3-97CC-28DBFE7A612FQ33732640-BD7F107C-68F7-4EF4-AE17-359484FA53EBQ34213378-D0F859F3-9A5C-47ED-B2FB-C4B3BBAC73B6Q34260546-02CEB809-32EC-4045-AFAC-0DE6F185EB73Q34979018-CD9D4844-D826-4018-9A9C-CF4F6874CA70Q35612633-ED14453D-0A0F-4474-8879-3209321409F6Q35822130-8EB103DC-9428-4B40-B2EC-1E4EAC8B33EBQ35891952-E0F393DE-63BB-4670-87AE-F90C8A65095CQ36560230-7C3B2868-034A-4A86-8AB2-0C30468E77DBQ36906207-C22B57EC-FEF7-4BEF-B59D-378CB844E04CQ36995370-87AD3F75-4E50-4EC0-8366-EA6B078BF545Q37364899-49DA716B-4B6F-4E15-8213-1F8BE6698775Q37408019-277C22D8-D5EC-41FB-8E7A-60EE11CC243CQ42508366-1236A4B7-6771-4E9B-B077-D39484FAD8B4Q42936615-DDB769AF-4677-4C7A-AD71-8468FB5CCE9DQ43225003-C723E77B-524C-4A74-8AD2-FC61B834131FQ48004863-8B4CC8E6-C94A-47FF-904A-A81D3FF82B62Q48329552-D7C6BAC5-647A-4D90-92E4-0BCFEE20B441Q51359361-D624F6FA-CFAA-4ECA-9FE3-AE29809217B7Q51483217-B59C566E-513A-4EC7-B7A8-EB605E4E6504Q57796323-FFA5FD2F-7C3F-4A34-A87C-7B9BE90EC3A6
P2860
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@en
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@nl
type
label
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@en
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@nl
prefLabel
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@en
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@nl
P2093
P1433
P1476
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
@en
P2093
Carla J Greenbaum
Immunology of Diabetes Society
Leonard C Harrison
P304
P356
10.2337/DIABETES.52.5.1059
P407
P577
2003-05-01T00:00:00Z